Sea cucumber and oyster peptide chewable tablet for nourishing liver, protecting kidney and resisting fatigue and preparation method thereof
An anti-fatigue and oyster peptide technology, applied in the field of compound biology, can solve problems such as liver and kidney organ cell damage, liver and kidney fatigue, work and rest, and eating irregularities
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] A chewable tablet of sea cucumber and oyster peptides provided in this example for nourishing the liver, protecting the kidney and resisting fatigue, each 1g of the chewable tablet includes the following ingredients:
[0055] Sea cucumber peptide 13mg, oyster peptide 100mg, casein phosphopeptide 5mg, whey protein concentrate 10mg, fruit and vegetable powder 100mg, lactose 1mg, xylooligosaccharide 1mg, resistant dextrin 1mg, fructooligosaccharide 1mg, chitooligosaccharide 10mg, vitamins C1mg, erythritol 0.5mg, sorbitol 15mg, citric acid 0.05mg, DL-malic acid 1mg, magnesium stearate 1mg; targeted sustained-release biocompatible microcapsules 20mg.
[0056] Among them, targeted slow-release biocompatible microcapsules, by weight components, include the following components: 15 parts of polycarbonate film with a pore size of 180 nm and a thickness of 30 mm; 12 parts of α-lactalbumin; 18 parts of amino acids; - 8 parts of carrageenan; 12 parts of lecithin; 25 parts of poly(2...
Embodiment 2
[0083] A chewable tablet of sea cucumber and oyster peptides provided in this example for nourishing the liver, protecting the kidney and resisting fatigue, each 1g of the chewable tablet includes the following ingredients:
[0084] Sea cucumber peptide 100mg, oyster peptide 13mg, casein phosphopeptide 70mg, whey protein concentrate 150mg, fruit and vegetable powder 10mg, lactose 4mg, xylooligosaccharide 0.6mg, resistant dextrin 5mg, fructooligosaccharide 10mg, chitooligosaccharide 1mg, Vitamin C 30mg, erythritol 10mg, sorbitol 0.5mg, citric acid 1mg, DL-malic acid 0.05mg, magnesium stearate 1mg; targeted sustained-release biocompatible microcapsules 30mg;
[0085] Targeted slow-release biocompatible microcapsules, by weight components, include the following components: 20 parts of polycarbonate film with a pore size of 250 nm and a thickness of 15 mm; 18 parts of α-lactalbumin; 12 parts of amino acids; κ- 12 parts of carrageenan; 8 parts of lecithin; 35 parts of poly(2-ethyl-...
Embodiment 3
[0111] A chewable tablet of sea cucumber and oyster peptides provided in this example for nourishing the liver, protecting the kidney and resisting fatigue, each 1g of the chewable tablet includes the following ingredients:
[0112] Sea cucumber peptide 55mg, oyster peptide 56mg, casein phosphopeptide 37.5mg, whey protein concentrate 80mg, fruit and vegetable powder 55mg, lactose 2.5mg, xylooligosaccharide 0.8mg, resistant dextrin 3mg, fructooligosaccharide 5.5mg, chitosan oligosaccharide Sugar 5.5mg, vitamin C 15.5mg, erythritol 5.25mg, sorbitol 7.75mg, citric acid 5mg, DL-malic acid 5.1mg, magnesium stearate 0.75mg; targeted slow-release biocompatible microcapsules 25mg ;
[0113] Targeted slow-release biocompatible microcapsules, by weight components, include the following components: 18 parts of polycarbonate film with a pore size of 200 nm and a thickness of 23 mm; 15 parts of α-lactalbumin; 15 parts of amino acid; κ- 10 parts of carrageenan; 10 parts of lecithin; 20 par...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com